ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

The Latest on X

Claim CME/CNE/CPE/MOC

Participants can claim CE/MOC by December 18, 2024.

Access Kidney Week Content

Recorded content is available in the ASN eLearning Center.

In order to view archived Kidney Week documents, please choose 'Past Kidney Weeks' on the side menu.

The World's Premier Nephrology Meeting

Kidney Week 2024 San Diego, CA

Thank You! To All Participants

ASN thanks the approximately 12,000 participants of Kidney Week 2024 from across the globe for another successful meeting.

Post Meeting Resources

View 2,500+ ePosters through December 5, 2024.
Claim CME/CNE/CPE/MOC by December 18, 2024.
Download the Certificate of Attendance through January 31, 2025.
Access recorded content in the ASN eLearning Center for 3 years.

Save The Date!

Kidney Week 2025 will be held November 5-9, 2025 at the George R. Brown Convention Center in Houston, TX.

Future Meeting Dates

Key Dates

October 22, 2024

Onsite Registration Opens in San Diego

October 23, 2024

Early Programs in San Diego

October 24-27, 2024

Annual Meeting

View All

Frequently Asked Questions

Learn more about Kidney Week 2024 in San Diego, CA and get answers to common questions.

Need Help?

Need help registering or locating something? Contact ASN for program assistance, technical support, and more.

#KidneyWk on X 1 day ago

Researchers studied the efficacy and safety of #dapagliflozin in patients with #CKD stages 4 and 5. #nephrology #nephtwitter #kidneydisease #kidney...

View Post

#KidneyWk on X 2 days ago

A study assessed the efficacy of adding sodium zirconium cyclosilicate to allow patients with stage 3-4 DKD to maintain RAASi use. #kidneywk #nepht...

View Post

#KidneyWk on X 3 days ago

The FALCON trial evaluated the safety and efficacy of bardoxolone methyl in patients with autosomal dominant polycystic kidney disease. #nephrology...

View Post

#KidneyWk on X Saturday, January 18 @ 6:10 AM

A substudy of POISE-3 data presented at #KidneyWk sought to find out whether a perioperative hypotension-avoidance strategy changes the risk of pos...

View Post

#KidneyWk on X Friday, January 17 @ 6:08 AM

RT @Neph_Times: A study examined the efficacy and safety of obinutuzumab to treat patients with focal segmental glomerulosclerosis who were…

View Post

#KidneyWk on X Friday, January 17 @ 5:46 AM

A study examined the efficacy and safety of obinutuzumab to treat patients with focal segmental glomerulosclerosis who were treatment-resistant or ...

View Post